Is Novartis a good candidate for swing trading?
It has been in an almost horizontal trend for 5 years. But it is also possible that it may break up based on fundamental conditions (1). Good product portfolio and pipeline and many blockbuster.
They pay about half of the profits out to the shareholder.
I don't have the stock, but will consider try get into, in the bottom of the trend.
Lately, price top and bottom coincide with volume top and bottom. On Volume Balance OVB neutral 22 days back.
There's a REC where there might be price breaks up or down. Obs formation does not fit so well with volume, but volume profile is OK.
RSI 21 about 50.
Oscillators and MA stand on buy one day and sell a week to a month.
Considers the stock technically neutral in the medium term.
Remember you need do your own research and assessment before buying and selling.
Sources
(1) fool.com/investing/2022/08/02/heres-why-income-investors-should-consider-buying/?source=eptyholnk0000202
(2) Trading view
It has been in an almost horizontal trend for 5 years. But it is also possible that it may break up based on fundamental conditions (1). Good product portfolio and pipeline and many blockbuster.
They pay about half of the profits out to the shareholder.
I don't have the stock, but will consider try get into, in the bottom of the trend.
Lately, price top and bottom coincide with volume top and bottom. On Volume Balance OVB neutral 22 days back.
There's a REC where there might be price breaks up or down. Obs formation does not fit so well with volume, but volume profile is OK.
RSI 21 about 50.
Oscillators and MA stand on buy one day and sell a week to a month.
Considers the stock technically neutral in the medium term.
Remember you need do your own research and assessment before buying and selling.
Sources
(1) fool.com/investing/2022/08/02/heres-why-income-investors-should-consider-buying/?source=eptyholnk0000202
(2) Trading view
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
